Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
---|
05/04/2006 | US20060094786 Treating syndrome X with substituted tetralins and indanes |
05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
05/04/2006 | US20060093932 Bisazo-based charge transport materials having 4-oxo-2,5-cyclohexadiene-1-ylidinyl groups |
05/04/2006 | CA2584664A1 (biphenyl) carboxylic acids and derivatives thereof |
05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
05/03/2006 | EP1651202A1 Compositions containing prodrugs of florfenicol and methods of use |
05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
05/03/2006 | CN1768032A Method for producing 3,3íõ-diallyl-4,4íõ-dihydroxydiphenylsulfone |
05/02/2006 | USRE39088 Amide compounds and use of the same |
05/02/2006 | US7037938 For therapy of urinary incontinence |
05/02/2006 | US7037930 3-arylphenyl sulfide derivative and insecticide and miticide |
04/27/2006 | WO2006043635A1 3-triazolylphenyl sulfide derivative and insecticide/acaricide/nematicide containing the same as active ingredient |
04/27/2006 | WO2006024412A3 Optically active phthalamides |
04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
04/27/2006 | CA2581725A1 3-triazolylphenyl sulfide derivative, and insecticide, miticide and nematicide containing it as an active ingredient |
04/26/2006 | CN1762994A Sulfonyl diphenylethyllene endocompound and its preparation method and pharmaceutical uses |
04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
04/20/2006 | WO2006041888A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents |
04/20/2006 | WO2006041119A1 Hydrazide derivatives |
04/20/2006 | WO2006040527A1 Process for making phenoxy benzamide compounds |
04/20/2006 | WO2006040180A1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
04/20/2006 | WO2006040179A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
04/20/2006 | US20060084647 Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof |
04/20/2006 | CA2583973A1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
04/20/2006 | CA2583918A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
04/20/2006 | CA2582459A1 Substituted sulfones and methods of use |
04/20/2006 | CA2581619A1 Process for making phenoxy benzamide compounds |
04/19/2006 | EP1646608A1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
04/19/2006 | CN1761646A Cannabinoid receptor ligands |
04/19/2006 | CN1252042C Oximate light initiator |
04/18/2006 | US7030262 3-Amino-2-hydroxyalkanoic acids and their prodrugs |
04/18/2006 | US7030116 Compounds and compositions as cathepsin inhibitors |
04/18/2006 | US7030109 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
04/18/2006 | CA2360943C N2-phenylamidine derivatives |
04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
04/13/2006 | US20060079713 Novel salt forms of poorly soluble probucol esters and ethers |
04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
04/13/2006 | US20060079706 N-[4-cyano-3-(trifluoro-methyl) phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide in crystalline form and amorphous bicalutamide; for use in treatment of prostate cancer |
04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
04/13/2006 | US20060079561 Insecticidal anthranilamides |
04/12/2006 | EP1644334A1 Antithrombotic ethers |
04/12/2006 | CN1250525C Purification of 2-nitro-4-methylsulphonylbenzoic acid |
04/12/2006 | CN1250209C Inhibitor for 20-hydroxy-eicosatetraenoic acid enzyme |
04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
04/11/2006 | US7026089 flexible organophotoreceptors comprising a bis(9-fluorenone-4-carboxyl)alkane sulfonyldiphenylenebishydrazone group, including polymers such as oligomers; produces high quality images that can be maintained after repeated cycling. |
04/11/2006 | US7025901 Liquid crystals; dielectric anisotropy |
04/11/2006 | CA2089440C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicaments containing them |
04/11/2006 | CA2089439C 3,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
04/06/2006 | WO2006035891A1 Isonitriles and antifouling agents against the adhesion of aquatics |
04/06/2006 | WO2005046854A3 A process for the preparation of diphenylmethylsulfinyl derivatives |
04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
04/06/2006 | US20060074130 2-{6-[1-Ethyl-3-(4-trifluoromethoxyphenyl)ureido]-5,6,7,8-tetrahydronaphthalen-2-ylsulfanyl}-2-methylpropionic acid; peroxisome proliferator activated receptors agonist; antidiabetic, dietetics, hypotensive and hypoglycemic agent; dyslipidemia |
04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
04/05/2006 | EP1641774A1 Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators |
04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
04/05/2006 | CN1754899A Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
04/05/2006 | CN1249020C Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
04/04/2006 | US7022869 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof |
04/04/2006 | CA2235765C Azulenyl nitrone spin trapping agents, methods of making and using same |
03/30/2006 | WO2006034006A1 Polymorphs of the cysteine protease inhibitor n- (1-cyanocyclopropyl)-3-cyclopropylmethansulfonyl-2 (r) - (2,2,2-trifluoro-1 (s) - (4-fluorophenyl) ethylamino) propionamide |
03/30/2006 | WO2006034004A2 Processes and intermediates for preparing cysteine protease inhibitors |
03/30/2006 | WO2006033446A1 Aminoalcohol derivatives |
03/30/2006 | WO2006032386A1 Lyophilisate containing n-diaminomethylene-2-methyl-4,5-di-(methylsulfonyl)-benzamide |
03/30/2006 | WO2005075417A8 Fluorosulfone compounds |
03/30/2006 | CA2581081A1 Lyophilisate containing n-diaminomethylene-2-methyl-4,5-di-(methylsulfonyl)-benzamide |
03/30/2006 | CA2580760A1 Aminoalcohol derivatives |
03/30/2006 | CA2580219A1 Polymorphs of the cysteine protease inhibitor n-(1-cyanocyclopropyl)-3-cyclopropylmethanesulfonyl-2(r)-(2,2,2-trifluoro-1(s)-(4-fluorophenyl) ethylamino)propionamide |
03/30/2006 | CA2580065A1 Processes and intermediates for preparing cysteine protease inhibitors |
03/29/2006 | EP1640366A1 Heterocyclic methyl sulfone derivative |
03/29/2006 | EP1638928A1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides |
03/29/2006 | EP1638927A1 Therapeutic agents |
03/29/2006 | CN1753867A Process for preparing benzhydrylthioacetamide |
03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
03/28/2006 | CA2153805C C10 taxane derivatives and pharmaceutical compositions |
03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
03/23/2006 | WO2006030278A1 Methods for the separation of modafinil |
03/23/2006 | WO2006029532A1 Nitrate esters and their use for mitigating cellular damage |
03/23/2006 | WO2006029436A1 Cox-ii inhibitor compounds |
03/23/2006 | WO2005121078A3 Substituted cyclopentene compounds |
03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
03/23/2006 | US20060063669 Recording material comprising diphenyl sulfone derivative and novel diphenyl sulfone derivative compound |
03/23/2006 | CA2575802A1 Methods for the separation of modafinil |
03/22/2006 | EP1637518A2 Inhibitors of aspartyl protease |
03/22/2006 | EP1636202A1 Method of producing an organic compound comprising at least one oxygenated functional group |
03/22/2006 | EP1636175A1 Novel compounds |
03/22/2006 | EP1315697B1 Herbicidal benzoyl cyclohexane dione |
03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
03/22/2006 | CN1751269A Halogenated oxime derivatives and the use thereof as latent acids |
03/22/2006 | CN1751037A Sulfonamide derivatives as PPAR modulators |
03/22/2006 | CN1751021A Crystalline forms of optical enantiomers of modafinil and method for the production |